ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 128 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $5,518,000 | -31.2% | 213,625 | -36.3% | 0.76% | -37.5% |
Q1 2018 | $8,018,000 | +68.4% | 335,500 | +138.8% | 1.22% | +117.7% |
Q4 2017 | $4,762,000 | +94.8% | 140,500 | +21.6% | 0.56% | +60.2% |
Q3 2017 | $2,445,000 | -28.5% | 115,500 | -40.9% | 0.35% | -39.9% |
Q2 2017 | $3,419,000 | -0.1% | 195,500 | 0.0% | 0.58% | -13.2% |
Q1 2017 | $3,421,000 | -25.0% | 195,500 | -27.6% | 0.67% | -42.1% |
Q4 2016 | $4,563,000 | +3.0% | 270,000 | 0.0% | 1.16% | +60.2% |
Q3 2016 | $4,431,000 | +8.4% | 270,000 | 0.0% | 0.72% | -32.0% |
Q2 2016 | $4,088,000 | +4.7% | 270,000 | 0.0% | 1.06% | +25.4% |
Q1 2016 | $3,904,000 | -8.1% | 270,000 | +80.0% | 0.85% | +36.0% |
Q4 2015 | $4,248,000 | – | 150,000 | – | 0.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
C Partners Holding GmbH | 1,662,128 | $29,037,000 | 9.28% |
GREAT POINT PARTNERS LLC | 608,650 | $10,645,000 | 4.68% |
Opaleye Management Inc. | 255,000 | $4,460,000 | 2.07% |
EMERALD MUTUAL FUND ADVISERS TRUST | 326,530 | $5,721,000 | 0.47% |
Granite Point Capital Management, L.P. | 61,813 | $1,076,000 | 0.39% |
WALL STREET ASSOCIATES | 225,000 | $3,935,000 | 0.37% |
EMERALD ADVISERS, LLC | 322,631 | $5,652,000 | 0.28% |
Spark Investment Management LLC | 75,500 | $1,317,000 | 0.18% |
TFS CAPITAL LLC | 98,443 | $1,722,000 | 0.17% |
PRIVATE ASSET MANAGEMENT INC | 47,690 | $834,000 | 0.14% |